ITGAM and neoplasm: Tumor-infiltrating MHC-II+/CD11b+/CD11chigh DCs (TIDCs) have been reported to suppress CD8+ T cell responses via the upregulation of arginase, inducing less proliferation and CD3ζ chain expression on T cells upon interaction (122).